Literature DB >> 10849244

Zolpidem and sleep deprivation: different effect on EEG power spectra.

H P Landolt1, L A Finelli, C Roth, A Buck, P Achermann, A A Borbély.   

Abstract

To study the role of GABA-ergic mechanisms in sleep regulation, the combined action of 40 h sleep deprivation and either 20 mg zolpidem or placebo on the sleep electroencephalogram (EEG) were investigated by quantitative EEG analysis in eight young men who participated in a positron emission tomography study. Compared with baseline, sleep deprivation increased low-frequency (1.25-7.0 Hz) EEG power in non-rapid eye movement (NREM) sleep in the placebo night. After administration of zolpidem, power in the 3.75-10.0 Hz range and 14. 25-16.0 Hz band was reduced. The largest decrease was observed in the theta band. Comparison with placebo revealed that zolpidem attenuated power in the entire 1.75-11.0 Hz range. The plasma concentration of zolpidem at 4.5 h after intake showed a positive correlation with the drug-induced difference in power from placebo in the 14.25-16.0 Hz band. Regional EEG analysis based on bipolar derivations along the antero-posterior axis disclosed, for NREM sleep, a drug-induced posterior shift of power in the frequency range of 7.75-9.75 Hz. Zolpidem did not affect rapid eye movemnt sleep spectra. We conclude that sleep deprivation and agonistic modulation of GABAA receptors have separate and additive effects on power spectra and that their effects are mediated by different neurophysiological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849244     DOI: 10.1046/j.1365-2869.2000.00192.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  14 in total

1.  Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype.

Authors:  I Tobler; C Kopp; T Deboer; U Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures.

Authors:  Fabiana Fratello; Giuseppe Curcio; Michele Ferrara; Cristina Marzano; Alessandro Couyoumdjian; Giovanna Petrillo; Mario Bertini; Luigi De Gennaro
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice.

Authors:  Wei-Min Qu; Xiao-Fang Yue; Yu Sun; Kun Fan; Chang-Rui Chen; Yi-Ping Hou; Yoshihiro Urade; Zhi-Li Huang
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

4.  Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice.

Authors:  Chloé Alexandre; Alberto Dordal; Ramon Aixendri; Antonio Guzman; Michel Hamon; Joëlle Adrien
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

Review 5.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

6.  Age-related changes in slow wave activity rise time and NREM sleep EEG with and without zolpidem in healthy young and older adults.

Authors:  Evan D Chinoy; Danielle J Frey; Daniel N Kaslovsky; Francois G Meyer; Kenneth P Wright
Journal:  Sleep Med       Date:  2014-05-23       Impact factor: 3.492

7.  Effects of GF-015535-00, a novel α1 GABA A receptor ligand, on the sleep-wake cycle in mice, with reference to zolpidem.

Authors:  Christelle Anaclet; Mei Zhang; Chunmei Zhao; Colette Buda; Laurent Seugnet; Jian-Sheng Lin
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

Review 8.  Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

Authors:  H P Landolt; J C Gillin
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

9.  Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia.

Authors:  Andrew D Krystal; Jack D Edinger
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

Review 10.  Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.